HRI’s Dr Marc Ellis has received the RCPA Kanematsu Research Award 2019 to support his research into how platelets become activated by turbulent blood flow, and why this process is increased in diabetes.
This prestigious award from the Royal College of Pathologists of Australasia (RCPA) Foundation is granted annually through the Kanematsu Fund, in memory of its founder Fusajiro Kanematsu and his wife, Sen.
Dr Ellis was awarded for his project ‘Investigating the role of the mechanosensitive ion channel Piezo1 in platelet function and diabetes’.
Dr Ellis is a haematologist working towards his PhD in HRI’s Thrombosis Group. His research interests surround the mechanisms of platelet activation under conditions of disturbed blood flow and how the process may be altered in conditions such as diabetes. You can read more about Dr Ellis’ research here.
